Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Heal

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Neuropharmacology|October 17, 1998
Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving ratsH L Rowley, I C Kilpatrick, P L Needham, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
European Journal of Pharmacology|April 22, 1983
Hypophysectomy alters both 5-hydroxytryptamine- and alpha 2-adrenoceptor-mediated behavioural changes in the ratD J Heal, K M O'Shaughnessy, S L Smith, et al.
Journal of Neural Transmission|January 1, 1986
Studies on rat brain catecholamine synthesis and beta-adrenoceptor number following administration of electroconvulsive shock, desipramine and clenbuterolV L Nimgaonkar, D J Heal, C L Davies, et al.
Neuropharmacology|May 29, 2023
Psychedelics: Threshold of a Therapeutic RevolutionD J Heal, S L Smith, S J Belouin, et al.
Psychopharmacology|January 1, 1990
An investigation of the role of 5-hydroxytryptamine in the attenuation of presynaptic alpha 2-adrenoceptor-mediated responses by antidepressant treatmentsD J Heal, E M Hurst, M R Prow, et al.
Pharmacology & Therapeutics|December 11, 2007
Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disordersD J Heal, S L Smith, A Fisas, et al.
European Journal of Pharmacology|November 2, 1993
Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioningD J Heal, S A Butler, M R Prow, et al.
Journal of Neurochemistry|October 1, 1989
Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortexD J Heal, S A Butler, E M Hurst, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Neural Transmission. General Section|January 1, 1995
D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic functionS C Cheetham, C J Kettle, K F Martin, et al.
Neuropharmacology|October 17, 1998
Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely moving ratsH L Rowley, I C Kilpatrick, P L Needham, et al.
Neuropharmacology|August 30, 2000
Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramineS C Cheetham, J A Viggers, N A Slater, et al.
European Journal of Pharmacology|April 22, 1983
Hypophysectomy alters both 5-hydroxytryptamine- and alpha 2-adrenoceptor-mediated behavioural changes in the ratD J Heal, K M O'Shaughnessy, S L Smith, et al.
Journal of Neural Transmission|January 1, 1986
Studies on rat brain catecholamine synthesis and beta-adrenoceptor number following administration of electroconvulsive shock, desipramine and clenbuterolV L Nimgaonkar, D J Heal, C L Davies, et al.
Neuropharmacology|May 29, 2023
Psychedelics: Threshold of a Therapeutic RevolutionD J Heal, S L Smith, S J Belouin, et al.
Psychopharmacology|January 1, 1990
An investigation of the role of 5-hydroxytryptamine in the attenuation of presynaptic alpha 2-adrenoceptor-mediated responses by antidepressant treatmentsD J Heal, E M Hurst, M R Prow, et al.
Pharmacology & Therapeutics|December 11, 2007
Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disordersD J Heal, S L Smith, A Fisas, et al.
European Journal of Pharmacology|November 2, 1993
Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioningD J Heal, S A Butler, M R Prow, et al.
Journal of Neurochemistry|October 1, 1989
Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortexD J Heal, S A Butler, E M Hurst, et al.
Pageof 10